Buy or sell: Ganesh Dongre of Anand Rathi recommends four stocks to buy on Monday – 28 April

Buy or sell: Over the past three weeks, the Nifty Index has demonstrated a strong recovery, fueled by Foreign Institutional Investors (FIIs) purchasing stocks worth ₹30,000 crore in the cash market. This bullish momentum was underpinned by both global and domestic factors, notably U.S. President Donald Trump’s decision to pause the implementation of steep reciprocal…

Read More

Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher

Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal. The acquisition will bolster Sun Pharma’s onco-dermatology portfolio, adding Checkpoint’s recently FDA-approved cancer drug, UNLOXCYT (cosibelimab-ipdl), to its pipeline. The deal, expected to close in the second quarter of the…

Read More

FPI sell-off, retail panic fuel sharp market correction; mid, small caps enter negative territory

On a day global stock indices were battered by rising international trade tensions induced by US President Donald Trump, Indian markets followed their slump, with all gauges dipping sharply. Japan’s Nikkei and China’s CSI 300 fell 2.88% and 1.97%, respectively, amid weak openings for Germany’s Dax and French CAC. Almost on cue, the Indian benchmarks—Nifty…

Read More

Eight stocks to buy and sell today—14 February

Two stocks to buy, recommended by MarketSmith India â—Ź Muthoot Finance Ltd: Current market price ₹ 2,317.8 | Buy range ₹ 2,270–2,330 | Profit goal ₹ 2,730 | Stop loss ₹ 2,120 | Timeframe 2–3 Months â—Ź Sun Pharmaceutical Industries Ltd: Current market price ₹ 1,746 | Buy range ₹ 1,720–1,760 | Profit goal ₹…

Read More
Back To Top